GoldenGolden
Advanced Search
Strand Therapeutics

Strand Therapeutics

Strand Therapeutics is a gene Therapy founded by Darrell Irvine, Jacob Becraft, Ron Weiss and Tasuku Kitada.

Established in 2017, Strand Therapeutics is the creator of a biotechnology platform intended to create gene therapies powered by synthetic biology.

Timeline

June 4, 2019
Strand Therapeutics raises a $6,000,000 seed round from ANRI, Alexandria Real Estate Equities, Creative Destruction Lab and Playground Global.

Funding rounds

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
BioSpace
June 30, 2021
BioSpace
Today, Strand Therapeutics, announced Jake Becraft, PhD, co-founder and CEO of Strand, has been named to MIT Technology Review's prestigious annual list of Innovators Under 35.

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.